MAY 06, 2019 07:17 AM PDT

New insights on childhood cancer

Malignant rhabdoid tumor (MRT) is one of the worst cancer diagnoses a child can receive. While it is uncommon (or perhaps because it is), there are no standard effective treatments for MRT and most children will survive under a year.

MRT is so aggressive because it involves the loss of an anti-cancer protein called SNF5. The inactivation of SNF5 means that tumors are not suppressed; at the same time, the lost SNF5 also enables a pro-cancer protein called MYC to accelerate cancerous growth. Understanding this relationship has guided new research from Vanderbilt University, as scientists believe that targeting MYC in MRT patients might provide an effective treatment option.

"One of the difficulties in treating a cancer like MRT is that it's driven by the loss of a particular protein from the tumor cell," said William Tansey, PhD, Ingram Professor of Cancer Research and Professor of Cell and Developmental Biology. "Showing that MYC is activated by SNF5 loss identifies a target you can conceivably go after in these cancers," he said.

MRT cancer is one of the most aggressive pediatric cancers. Photo: Pixabay

MYC refers to a group of three related proteins that work as transcriptional regulators, meaning they control the expression of many genes linked to cell growth, proliferation, metabolism and genomic instability. In people with cancer, these proteins are expressed too much, which result in malignant tumors and cancerous growth. MYC overexpression leads to 100,000 cancer deaths annually in the United States.

Tansey and his colleagues are hoping that this new understanding of the connection between SNF5 and MYC proteins will promote future research in the field. As reported by Science Daily, the team of researchers utilized biochemical and genomic approaches to show that “SNF5 selectively inhibited binding of MYC to DNA, something that is required for its tumorigenic function. Accordingly, the reintroduction of SNF5 into MRT cells also displaced MYC from chromatin (the complex of DNA, RNA and protein that form chromosomes), inhibiting pro-cancerous gene expression programs.”

The research was published recently in the journal Nature Communications.

Sources: Nature Communications, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 19, 2019
Drug Discovery
AUG 19, 2019
First PI3K Inhibitor for Breast Cancer
The U.S. Food and Drug Administration has approved Piqray (alpelisib) tablets, to be used in conjunction with FDA-approved endocrine therapy fulvestrant fo...
AUG 19, 2019
Microbiology
AUG 19, 2019
Novel Pathogens Identified in Cow's Milk and Beef
This new type of pathogen is thought to be something in between a bacterium and a virus....
AUG 19, 2019
Cancer
AUG 19, 2019
Post-breast cancer women have a higher risk of heart disease
Can’t women get a break? Apparently not, according to new research from the Botucatu Medical School at Paulista State University in Sao Paulo, Brazil...
AUG 19, 2019
Health & Medicine
AUG 19, 2019
Wi-Fi Poses A Growing Health Risk
Groups linked to the telecommunications industry claim there are no possible health impacts related to Wi-Fi use. Several recent studies signal that the op...
AUG 19, 2019
Health & Medicine
AUG 19, 2019
Does Cuttlefish Ink Hold a Cure for Cancer?
Using nanoparticles to deliver cancer-fighting compounds directly into tumors has been a hot research topic for the past few years. According to Lisa Ayga...
AUG 19, 2019
Cancer
AUG 19, 2019
What zebra fish tell us about cancer tumors
New research published in PNAS from researchers at Duke University highlights a surprising finding: zebrafish have the ability to shed the lining of their ...
Loading Comments...